专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明申请

US20080207687A1 Quinoline Derivatives as Antibacterial Agents 有权
公开(公告)号：US20080207687A1
公开(公告)日：2008-08-28
申请号：US11997173
申请日：2006-07-31
申请人： Jerome Emile Georges Guillemont , Elisabeth Therese Jeanne Pasquier , David Francis Alain Lancois , Koenraad Jozef Lodewijk Marcel Andries , Anil Koul , Leo Jacobus Jozef Backx , Lieven Meerpoel
发明人： Jerome Emile Georges Guillemont , Elisabeth Therese Jeanne Pasquier , David Francis Alain Lancois , Koenraad Jozef Lodewijk Marcel Andries , Anil Koul , Leo Jacobus Jozef Backx , Lieven Meerpoel
IPC分类号： A61K31/47 , A61P31/04 , C07D215/227
CPC分类号： C07D215/227 , A61K31/47
摘要： Use of a compound for the manufacture of a medicament for the treatment of a bacterial infection provided that the bacterial infection is other than a Mycobacterial infection, said compound being a compound of formula (I) a pharmaceutically acceptable acid or base addition salt, a quaternary amine, a stereochemically isomeric form, a tautomeric form or a N-oxide form thereof, wherein R1 is hydrogen, halo, haloalkyl, cyano, hydroxy, Ar, Het, alkyl, alkyloxy, alkylthio, alkyloxyalkyl, alkylthioalkyl, Ar-alkyl or di(Ar)alkyl; p is 1 to 3; s is 0 to 4; R2 is hydrogen; halo; alkyl; hydroxy; mercapto; optionally substituted alkyloxy; alkyloxyalkyloxy; alkylthio; mono or di(alkyl)amino wherein alkyl may optionally be substituted; Ar; Het or a radical of formula R3 is alkyl, Ar, Ar-alkyl, Het or Het-alkyl; q is 0 to 4; R4 and R5 each independently are hydrogen, alkyl or benzyl; or R4 and R5 may be taken together including the N to which they are attached; R6 is hydrogen, halo, haloalkyl, hydroxy, Ar, alkyl, alkyloxy, alkylthio, alkyloxyalkyl, alkylthioalkyl, Ar-alkyl or di(Ar)alkyl; or two vicinal R6 radicals may be taken together to form together with the phenyl ring to which they are attached a naphthyl; r is 1 to 5; R7 is hydrogen, alkyl, Ar or Het; R8 is hydrogen, alkyl, hydroxyl, aminocarbonyl, mono- or di(alkyl)aminocarbonyl, Ar, Het, alkyl substituted with one or two Het, alkyl substituted with one or two Ar, Het-C(═O)— or Ar—C(═O)—; provided that when the R3 bearing radical is placed in position 3 of the quinoline moiety; R7 is placed in position 4 and R2 is placed in position 2 and represents hydrogen, hydroxy, mercapto, alkyloxy, alkyloxyalkyloxy, alkylthio, mono or di(alkyl)amino or a radical of formula then s is 1 to 4.

2. 发明申请

US20080255116A1 Quinoline Derivatives as Antibacterial Agents 有权
标题翻译：喹啉衍生物作为抗菌剂
公开(公告)号：US20080255116A1
公开(公告)日：2008-10-16
申请号：US11997182
申请日：2006-07-31
申请人： Koenraad Jozef Lodewijk Marcel Andries , Anil Koul , Jerome Emile Georges Guillemont , Elisabeth Therese Jeanne Pasquier , David Francis Alain Lancois
发明人： Koenraad Jozef Lodewijk Marcel Andries , Anil Koul , Jerome Emile Georges Guillemont , Elisabeth Therese Jeanne Pasquier , David Francis Alain Lancois
IPC分类号： A61K31/4709 , C07D215/20 , C07D405/02 , C07D401/04 , C07D413/04 , A61P31/04 , A61K31/5377 , A61K31/496 , A61K31/4704
CPC分类号： C07D215/227 , A61K31/47 , Y02A50/473
摘要： Use of a compound for the manufacture of a medicament for the treatment of a bacterial infection provided that the bacterial infection is other than a Mycobacterial infection, said compound being a compound of Formula (Ia) or (Ib) a pharmaceutically acceptable acid or base addition salt thereof, a quaternary amine thereof, a stereochemically isomeric form thereof, a tautomeric form thereof or a N-oxide form thereof, wherein R1 is hydrogen, halo, haloalkyl, cyano, hydroxy, Ar, Het, alkyl, alkyloxy, alkylthio, alkyloxyalkyl, alkylthioalkyl, Ar-alkyl or di(Ar)alkyl; p is 1, 2 or 3; R2 is hydrogen; alkyl; hydroxy; mercapto; optionally substituted alkyloxy; alkyloxyalkyloxy; alkylthio; mono or di(alkyl)amino wherein alkyl may optionally be substituted; Ar; Het or a radical of formula R3 is alkyl, Ar, Ar-alkyl, Het or Het-alkyl; q is zero, 1, 2, 3 or 4; X is a direct bond or CH2; R4 and R5 each independently are hydrogen, alkyl or benzyl; or R4 and R5 may be taken together including the N to which they are attached; R6 is hydrogen or a radical of formula R7 is hydrogen, alkyl, Ar or Het; R8 is hydrogen or alkyl; R9 is oxo; or R8 and R9 together form the radical —CH═CH—N═;
摘要翻译：使用化合物制造用于治疗细菌感染的药物，只要细菌感染不是分枝杆菌感染，所述化合物是式（Ia）或（Ib）的化合物，其药学上可接受的酸或碱加成其盐，其季胺，其立体化学异构形式，其互变异构形式或其N-氧化物形式，其中R 1是氢，卤素，卤代烷基，氰基，羟基，Ar，Het 烷基，烷氧基，烷硫基，烷氧基烷基，烷硫基烷基，芳烷基或二（Ar）烷基; p为1,2或3; R 2是氢; 烷基; 羟基; 巯基任选取代的烷氧基; 烷氧基烷氧基; 烷硫基单或二（烷基）氨基，其中烷基可任选被取代; Ar; Het或式R 3的基团是烷基，Ar，Ar-烷基，Het或Het-烷基; q为零，1,2,3或4; X是直接键或CH 2 N 2; R 4和R 5各自独立地是氢，烷基或苄基; 或R 4和R 5可以一起包括它们所连接的N; R 6是氢或式R 7的基团是氢，烷基，Ar或Het; R 8是氢或烷基; R 9是氧代; 或R 8和R 9一起形成基团-CH-CH-N-;

3. 发明申请

US20100048585A1 QUINOLINE DERIVATIVES AS ANTIBACTERIAL AGENTS 有权
标题翻译：喹诺酮衍生物作为抗菌剂
公开(公告)号：US20100048585A1
公开(公告)日：2010-02-25
申请号：US11993145
申请日：2006-06-26
申请人： Koenraad Jozef Lodewijk Marcel Andries , Anil Koul , Jérôme Emile Georges Guilliemont , David Francis Alain Lancois , Magali Madeleine Simone Motte , Ismet Dorange , Leo Jacobus Jozef Backx , Lieven Meerpoel
发明人： Koenraad Jozef Lodewijk Marcel Andries , Anil Koul , Jérôme Emile Georges Guilliemont , David Francis Alain Lancois , Magali Madeleine Simone Motte , Ismet Dorange , Leo Jacobus Jozef Backx , Lieven Meerpoel
IPC分类号： A61K31/497 , C07D215/20 , C07D401/10 , C07D405/10 , C07D213/02 , A61K31/47 , A61K31/4439 , A61K31/443 , A61K31/4545 , A61P31/04
CPC分类号： A61K31/47 , C07D215/227
摘要： Use of a compound for the manufacture of a medicament for the treatment of a bacterial infection provided that the bacterial infection is other than a Mycobacterial infection, said compound being a compound of formula (Ia) or (Ib) a pharmaceutically acceptable acid or base addition salt thereof, a stereochemically isomeric form thereof, a tautomeric form thereof or a N-oxide form thereof, wherein R1 is hydrogen, halo, haloalkyl, cyano, hydroxy, Ar, Het, alkyl, alkyloxy, alkylthio, alkyloxyalkyl, alkylthioalkyl, Ar-alkyl or di(Ar)alkyl; p is 1, 2, 3 or 4; R2 is hydrogen, hydroxy, mercapto, alkyloxy, alkyloxyalkyloxy, alkylthio, mono or di(alkyl)amino or a radical of formula; R3 is alkyl, Ar, Ar-alkyl, Het or Het-alkyl; q is 1, 2 or 3; R4 and R5 are hydrogen, alkyl or benzyl; or R4 and R5 together and including the N to which they are attached may form a ring; R6 is hydrogen, halo, haloalkyl, hydroxy, Ar, alkyl, alkyloxy, alkylthio, alkyloxyalkyl, alkythioalkyl, Ar-alkyl or di(Ar)alkyl; or two vicinal R6 radicals may be taken together to form a bivalent radical of formula —CH═CH—CH═CH—; r is 1, 2, 3, 4 or 5; R7 is hydrogen, alkyl, Ar or Het; R8 is hydrogen or alkyl; R9 is oxo; or R8 and R9 together form the radical —CH═CH—N═.
摘要翻译：使用化合物制造用于治疗细菌感染的药物，只要细菌感染不是分枝杆菌感染，所述化合物是式（Ia）或（Ib）的化合物，其药学上可接受的酸或碱加成其盐，其立体化学异构形式，其互变异构形式或其N-氧化物形式，其中R 1是氢，卤素，卤代烷基，氰基，羟基，Ar，Het，烷基，烷氧基，烷硫基，烷氧基烷基，烷硫基烷基，烷基或二（Ar）烷基; p为1,2,3或4; R2是氢，羟基，巯基，烷氧基，烷氧基烷氧基，烷硫基，一或二（烷基）氨基或式的基团; R3是烷基，Ar，Ar-烷基，Het或Het-烷基; q为1,2或3; R4和R5是氢，烷基或苄基; 或R 4和R 5一起并包括它们所连接的N可以形成环; R 6是氢，卤素，卤代烷基，羟基，Ar，烷基，烷氧基，烷硫基，烷氧基烷基，链仲烷基，芳烷基或二（Ar）或两个连位的R6基团可以一起形成式-CH = CH-CH = CH-的二价基团; r为1,2,3,4或5; R7是氢，烷基，Ar或Het; R8是氢或烷基; R9是氧代; 或R8和R9一起形成基团-CH = CH-N =。

4. 发明申请

US20080182855A1 Antibacterial Quinoline Derivatives 有权
标题翻译：抗菌喹啉衍生物
公开(公告)号：US20080182855A1
公开(公告)日：2008-07-31
申请号：US11996786
申请日：2006-07-26
申请人： Jerome Emile Georges Guillemont , David Francis Alain Lancois , Elisabeth Therese Jeanne Pasquier , Koenraad Jozef Lodewijk Andries , Anil Koul
发明人： Jerome Emile Georges Guillemont , David Francis Alain Lancois , Elisabeth Therese Jeanne Pasquier , Koenraad Jozef Lodewijk Andries , Anil Koul
IPC分类号： A61K31/496 , C07D215/12 , A61K31/47 , A61P31/04 , A61K31/4709 , C07D401/12
CPC分类号： C07D215/227 , C07D215/12 , C07D215/48 , C07D401/04 , C07D401/06 , C07D401/12 , C07D401/14 , C07D405/06 , C07D405/12 , C07D413/06 , C07D417/06
摘要： The present invention relates to novel substituted quinoline derivatives according to the general Formula (Ia) or Formula (Ib): the pharmaceutically acceptable acid or base addition salts thereof, the quaternary amines thereof, the stereochemically isomeric forms thereof, the tautomeric forms thereof and the N-oxide forms thereof. The claimed compounds are useful for the treatment of a bacterial disease including a mycobacterial disease, particularly those diseases caused by pathogenic mycobacteria such as Mycobacterium tuberculosis, M. bovis, M. avium and M. marinum. Also claimed is a composition comprising a pharmaceutically acceptable carrier and, as active ingredient, a therapeutically effective amount of the claimed compounds, the use of the claimed compounds or compositions for the manufacture of a medicament for the treatment of bacterial diseases and a process for preparing the claimed compounds.
摘要翻译：本发明涉及根据通式（Ia）或式（Ib）的新的取代喹啉衍生物：其药学上可接受的酸或碱加成盐，其季胺，其立体化学异构形式，其互变异构形式和 N-氧化物形式。所要求保护的化合物可用于治疗细菌性疾病，包括分枝杆菌病，特别是由致病性分枝杆菌引起的疾病，例如结核分枝杆菌，牛分枝杆菌，鸟分枝杆菌和马氏海绵体。还要求保护的是包含药学上可接受的载体和作为活性成分的治疗有效量的要求保护的化合物的组合物，所要求保护的化合物或组合物在制备用于治疗细菌性疾病的药物中的用途以及制备方法要求保护的化合物。

5. 发明申请

US20100197727A1 Quinoline Derivatives as Antibacterial Agents 审中-公开
标题翻译：喹啉衍生物作为抗菌剂
公开(公告)号：US20100197727A1
公开(公告)日：2010-08-05
申请号：US11917091
申请日：2006-06-26
申请人： Koenraad Jozef Lodewijk Marcel Andries , Anil Koul , David Francis Alain Lancois , Magali Madeleine Simone Motte , Jérôme Emile Georges Guillemont
发明人： Koenraad Jozef Lodewijk Marcel Andries , Anil Koul , David Francis Alain Lancois , Magali Madeleine Simone Motte , Jérôme Emile Georges Guillemont
IPC分类号： A61K31/47 , C07D215/227 , C07D409/06 , A61K31/4709 , C07D401/06 , C07D215/36 , A61P31/04
CPC分类号： C07D409/06 , A61K31/47 , A61K31/4709 , C07D215/227 , C07D215/36 , C07D401/06
摘要： Use of a compound for the manufacture of a medicament for the treatment of a bacterial infection provided that the bacterial infection is other than a Mycobacterial infection, said compound being a compound of formula (Ia) or (Ib) a N-oxide, a tautomeric form or a stereochemically isomeric form thereof wherein A− is a counter ion; R1 is hydrogen, halo, haloalkyl, cyano, hydroxy, Ar, Het, alkyl, alkyloxy, alkylthio, alkyloxyalkyl, alkylthioalkyl, Ar-alkyl or di(Ar)alkyl; p is 1 to 4; R2 is hydrogen, hydroxy, mercapto, alkyloxy, alkyloxyalkyloxy, alkylthio, mono or di(alkyl)amino or wherein Y is CH2, O, S, NH or N-alkyl; R3 is alkyl, Ar, Ar-alkyl, Het or Het-alkyl; q is 0 to 4; R4 and R5 each independently are hydrogen, alkyl or benzyl; or R4 and R5 may be taken together including the N to which they are attached; R6 is hydrogen, halo, haloalkyl, hydroxy, Ar, alkyl, alkyloxy, alkylthio, alkyloxyalkyl, alkylthioalkyl, Ar-alkyl or di(Ar)alkyl; or two vicinal R6 radicals may be taken together to form —CH═CH—CH═CH—; r is 1 to 5; R7 is hydrogen, alkyl, Ar or Het; R8 is hydrogen or alkyl; R9 is oxo; or R8 and R9 taken together form —CH═CH—N═; R10 is alkyl, alkylcarbonyl, Ar, Ar-alkyl, Ar-carbonyl, Het1-alkyl or Het1-carbonyl.
摘要翻译：使用化合物制造用于治疗细菌感染的药物，只要细菌感染不是分枝杆菌感染，所述化合物是式（Ia）或（Ib）的化合物，N-氧化物，互变异构体形式或其立体化学异构体形式，其中A-是抗衡离子; R 1是氢，卤素，卤代烷基，氰基，羟基，Ar，Het，烷基，烷氧基，烷硫基，烷氧基烷基，烷硫基烷基，芳烷基或二（Ar） p为1〜4; R2是氢，羟基，巯基，烷氧基，烷氧基烷氧基，烷硫基，一或二（烷基）氨基或其中Y是CH2，O，S，NH或N-烷基; R3是烷基，Ar，Ar-烷基，Het或Het-烷基; q为0〜4; R4和R5各自独立地为氢，烷基或苄基; 或R4和R5可以一起包括它们所连接的N; R 6是氢，卤素，卤代烷基，羟基，Ar，烷基，烷氧基，烷硫基，烷氧基烷基，烷硫基烷基，芳烷基或二（Ar）或两个连位的R6基团可以一起形成-CH = CH-CH = CH-; r为1〜5; R7是氢，烷基，Ar或Het; R8是氢或烷基; R9是氧代; 或R8和R9一起形成-CH = CH-N =; R10是烷基，烷基羰基，Ar，Ar-烷基，Ar-羰基，Het1-烷基或Het1-羰基。

6. 发明申请

US20110124870A1 NOVEL MYCOBACTERIAL INHIBITORS 审中-公开
标题翻译：新型MYCOBACTERIAL INHIBITORS
公开(公告)号：US20110124870A1
公开(公告)日：2011-05-26
申请号：US13020079
申请日：2011-02-03
申请人： Jérôme Emile Georges GUILLEMONT , Elisabeth Therese Jeanne Pasquier , David Francis Alain Lancois
发明人： Jérôme Emile Georges GUILLEMONT , Elisabeth Therese Jeanne Pasquier , David Francis Alain Lancois
IPC分类号： C07D405/04 , C07D409/04 , C07D215/14
CPC分类号： C07D215/14 , C07D215/227 , C07D215/38 , C07D401/04 , C07D401/12 , C07D401/14 , C07D405/04 , C07D405/06 , C07D405/12 , C07D405/14 , C07D409/04 , C07D409/14
摘要： The present invention relates to novel substituted quinoline derivatives according to the general Formula (Ia) or the general Formula (Ib) the pharmaceutically acceptable acid or base addition salts thereof, the quaternary amines thereof, the stereochemically isomeric forms thereof, the tautomeric forms thereof and the N-oxide forms thereof. The claimed compounds are useful for the treatment of mycobacterial diseases. In particular, compounds are claimed in which, independently from each other, R1 is halo; p=1; R2 is optionally substituted alkyloxy, alkyl, Ar, Het, or a radical of formula R3 is optionally substituted Ar or Het; q=1, R4 and R5 each independently are alkyl; R6 is hydrogen or a radical of formula r is equal to 0 or 1 and R7 is hydrogen or Ar. Also claimed is a composition comprising a pharmaceutically acceptable carrier and, as active ingredient, a therapeutically effective amount of the claimed compounds, the use of the claimed compounds or compositions for the manufacture of a medicament for the treatment of mycobacterial diseases and a process for preparing the claimed compounds.
摘要翻译：本发明涉及根据通式（Ia）或通式（Ib）的新的取代喹啉衍生物，其药学上可接受的酸或碱加成盐，其季胺，其立体化学异构形式，其互变异构形式和其N-氧化物形式。所要求保护的化合物可用于治疗分枝杆菌病。特别地，要求保护的化合物，其中R1彼此独立地为卤素; p = 1; R 2是任选取代的烷氧基，烷基，Ar，Het或式R3的基团是任选取代的Ar或Het; q = 1，R4和R5各自独立地为烷基; R6是氢或式r的基团等于0或1，而R7是氢或Ar。还要求保护的是包含药学上可接受的载体和作为活性成分的治疗有效量的要求保护的化合物的组合物，所要求保护的化合物或组合物在制备用于治疗分枝杆菌疾病的药物中的用途以及制备方法要求保护的化合物。

7. 发明授权

US07902225B2 Mycobacterial inhibitors 有权
标题翻译：分枝杆菌抑制剂
公开(公告)号：US07902225B2
公开(公告)日：2011-03-08
申请号：US10596270
申请日：2005-01-21
申请人： Jérôme Emile Georges Guillemont , Elisabeth Therese Jeanne Pasquier , David Francis Alain Lancois
发明人： Jérôme Emile Georges Guillemont , Elisabeth Therese Jeanne Pasquier , David Francis Alain Lancois
IPC分类号： C07D215/38 , A61K31/04
CPC分类号： C07D215/14 , C07D215/227 , C07D215/38 , C07D401/04 , C07D401/12 , C07D401/14 , C07D405/04 , C07D405/06 , C07D405/12 , C07D405/14 , C07D409/04 , C07D409/14
摘要： The present invention relates to novel substituted quinoline derivatives according to the general Formula (Ia) or the general Formula (Ib) the pharmaceutically acceptable acid or base addition salts thereof, the quaternary amines thereof, the stereochemically isomeric forms thereof the tautomeric forms thereof and the N-oxide forms thereof. The claimed compounds are useful for the treatment of mycobacterial diseases. In particular, compounds are claimed in which, independently from each other, R1 is halo; p=1; R2 is optionally substituted alkyloxy, alkyl, Ar, Het, or a radical of formula R3 is optionally substituted Ar or Het; q=1, R4 and R5 each independently are alkyl; R6 is hydrogen or a radical of formula r is equal to 0 or 1 and R7 is hydrogen or Ar. Also claimed is a composition comprising a pharmaceutically acceptable carrier and, as active ingredient, a therapeutically effective amount of the claimed compounds, the use of the claimed compounds or compositions for the manufacture of a medicament for the treatment of mycobacterial diseases and a process for preparing the claimed compounds.
摘要翻译：本发明涉及根据通式（Ia）或通式（Ib）的新的取代喹啉衍生物，其药学上可接受的酸或碱加成盐，其季胺，其互变异构形式的立体化学异构形式和 N-氧化物形式。所要求保护的化合物可用于治疗分枝杆菌病。特别地，要求保护的化合物，其中R1彼此独立地为卤素; p = 1; R 2是任选取代的烷氧基，烷基，Ar，Het或式R3的基团是任选取代的Ar或Het; q = 1，R4和R5各自独立地为烷基; R6是氢或式r的基团等于0或1，而R7是氢或Ar。还要求保护的是包含药学上可接受的载体和作为活性成分的治疗有效量的要求保护的化合物的组合物，所要求保护的化合物或组合物在制备用于治疗分枝杆菌疾病的药物中的用途以及制备方法要求保护的化合物。

8. 发明授权

US07790894B2 Mycobacterial inhibitors 有权
标题翻译：分枝杆菌抑制剂
公开(公告)号：US07790894B2
公开(公告)日：2010-09-07
申请号：US11422152
申请日：2006-06-05
申请人： Jérôme Emile Georges Guillemont , Elisabeth Therese Jeanne Pasquier , David Francis Alain Lancois
发明人： Jérôme Emile Georges Guillemont , Elisabeth Therese Jeanne Pasquier , David Francis Alain Lancois
IPC分类号： C07D215/00 , C07D215/12 , C07D215/04
CPC分类号： C07D215/18
摘要： The present invention relates to novel substituted quinoline derivatives according to the general Formula (I) and pharmaceutically acceptable addition salts thereof, wherein the variable moieties are as defined in the specification. The invention also relates to a method of treating of mycobacterial diseases through administration of the claimed compounds and a process for preparing the claimed compounds.
摘要翻译：本发明涉及根据通式（I）的新的取代喹啉衍生物及其药学上可接受的加成盐，其中可变部分如说明书中所定义。本发明还涉及通过施用所要求保护的化合物治疗分枝杆菌疾病的方法和制备所要求保护的化合物的方法。

9. 发明申请

US20100048566A1 ANTIBACTERIAL QUINOLINE DERIVATIVES 有权
标题翻译：抗生素喹啉衍生物
公开(公告)号：US20100048566A1
公开(公告)日：2010-02-25
申请号：US12516065
申请日：2007-12-04
申请人： Jérôme Emile Georges Guillemont , David Francis Alain Lancois , Ismet Dorange , Koenraad Josef Lodewijk Andries , Anil Koul
发明人： Jérôme Emile Georges Guillemont , David Francis Alain Lancois , Ismet Dorange , Koenraad Josef Lodewijk Andries , Anil Koul
IPC分类号： A61K31/5377 , C07D215/00 , A61K31/47 , C07D401/06 , C07D401/10 , A61K31/497 , C07D413/02
CPC分类号： C07D215/14 , C07D401/04 , C07D413/04 , C07D417/04
摘要： The present invention relates to novel substituted quinoline derivatives according to the general Formula (Ia) or Formula (Ib): including any stereochemically isomeric form thereof, a N-oxide thereof, a pharmaceutically acceptable salt thereof or a solvate thereof.The claimed compounds are useful for the treatment of a bacterial infection. Also claimed is a composition comprising a pharmaceutically acceptable carrier and, as active ingredient, a therapeutically effective amount of the claimed compounds, the use of the claimed compounds or compositions for the manufacture of a medicament for the treatment of a bacterial infection and a process for preparing the claimed compounds.
摘要翻译：本发明涉及根据通式（Ia）或式（Ib）的新的取代喹啉衍生物：包括其任何立体化学异构形式，其N-氧化物，其药学上可接受的盐或其溶剂合物。所要求保护的化合物可用于治疗细菌感染。还要求保护的是包含药学上可接受的载体和作为活性成分的治疗有效量的要求保护的化合物的组合物，所要求保护的化合物或组合物在制备用于治疗细菌感染的药物中的用途和制备所要求保护的化合物。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式